Facial lesions heralding the onset and relapse of eosinophilic fasciitis.
Department of Internal Medicine, Tenon Hospital (AP-HP), Paris, France.
C
C
Bachmeyer
Department of Pathology, Tenon Hospital (AP-HP), Paris, France.
P
P
Moguelet
Department of Internal Medicine, Tenon Hospital (AP-HP), Paris, France.
C
C
Rein
Department of Hematology, Tenon Hospital (AP-HP), Paris, France.
R
R
Girot
D000328:Adult; D001168:Arthritis / Q000209:etiology; D001706:Biopsy; D002908:Chronic Disease / Q000188:drug therapy; D003078:Colchicine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004487:Edema / Q000209:etiology; D004802:Eosinophilia / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D005205:Fascia / Q000000981:diagnostic imaging / Q000473:pathology*; D005208:Fasciitis / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology*; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D008297:Male; D063806:Myalgia / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D013585:Synovitis / Q000209:etiology; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D014900:West Indies
D014810:Vitamin E; D014580:Ursodeoxycholic Acid; D005492:Folic Acid; C012852:colchiceine; D003078:Colchicine; D011241:Prednisone